Lantern Pharma Inc.
3.53
0.04 (1.15%)
At close: Jan 15, 2025, 3:59 PM
3.53
-0.01%
After-hours Jan 15, 2025, 04:00 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -2.91 -4.65 -7.08 -20.27 -38.57 -53.84
PS Ratio n/a n/a n/a n/a n/a n/a
PB Ratio 1.13 1.17 1.22 6.08 99.29 -460.62
P/FCF Ratio -3.23 -5.12 -8.2 -21.13 -43.9 -73.1
P/OCF Ratio -3.23 -5.13 -8.22 -21.19 -44.02 -73.1
OCF/S Ratio n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.01 0.00 0.00 0.01 n/a n/a
Quick Ratio 16.18 21.20 31.34 36.64 2.52 0.68
Current Ratio 16.18 20.99 31.26 36.64 2.52 0.68
Asset Turnover n/a n/a n/a n/a n/a n/a
Interest Coverage n/a -70.63 n/a n/a n/a n/a
Return on Equity (ROE) -0.39 -0.25 -0.17 -0.3 -2.57 8.56
Return on Assets (ROA) -0.37 -0.24 -0.17 -0.29 -1.69 -3.84
Return on Capital (ROIC) -0.44 -0.26 -0.18 -0.3 -2.57 8.56
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a